We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$71.7B
AUM Growth
+$2.34B
Cap. Flow
+$1.49B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.97%
Holding
3,809
New
183
Increased
1,708
Reduced
1,572
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 10.59%
2 Financials 9.51%
3 Healthcare 8.04%
4 Industrials 6.62%
5 Communication Services 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FXU icon
501
First Trust Utilities AlphaDEX Fund
FXU
$825M
$22.5M 0.03%
759,087
-114,910
-13% -$3.33M
ALXN
502
DELISTED
Alexion Pharmaceuticals
ALXN
$22.5M 0.03%
229,501
-47,805
-17% -$5.39M
TU icon
503
Telus
TU
$15.3B
$22.4M 0.03%
1,256,760
+86,860
+7% +$1.58M
PINC
504
DELISTED
Premier
PINC
$22.3M 0.03%
772,193
+144
+0% +$5.36K
KR icon
505
Kroger
KR
$34.8B
$22.3M 0.03%
865,828
+92,757
+12% +$2.16M
WDAY icon
506
Workday
WDAY
$44.4B
$22.3M 0.03%
131,156
-4,006
-3% -$773K
FCX icon
507
Freeport-McMoran
FCX
$97.5B
$22.2M 0.03%
2,317,644
-128,444
-5% -$1.32M
Y
508
DELISTED
Alleghany Corp
Y
$22.2M 0.03%
27,761
+1,229
+5% +$904K
CNI icon
509
Canadian National Railway
CNI
$76.6B
$21.9M 0.03%
243,852
+2,423
+1% +$224K
LDOS icon
510
Leidos
LDOS
$17.3B
$21.9M 0.03%
254,684
-34,758
-12% -$2.91M
INTU icon
511
Intuit
INTU
$89B
$21.7M 0.03%
81,653
+13,864
+20% +$3.81M
SBRA icon
512
Sabra Healthcare REIT
SBRA
$5.37B
$21.7M 0.03%
945,450
-2,284
-0.2% -$48.7K
VNOM icon
513
Viper Energy
VNOM
$14.7B
$21.7M 0.03%
783,076
-104,275
-12% -$3.11M
AMAT icon
514
Applied Materials
AMAT
$428B
$21.5M 0.03%
431,063
-22,695
-5% -$1.1M
GGG icon
515
Graco
GGG
$13.5B
$21.5M 0.03%
466,580
+296
+0.1% +$14K
SABR icon
516
Sabre
SABR
$835M
$21.4M 0.03%
957,109
-263
-0% -$6.19K
BIP icon
517
Brookfield Infrastructure Partners
BIP
$18B
$21.4M 0.03%
726,279
-3,595
-0.5% -$97.5K
SH icon
518
ProShares Short S&P500
SH
$843M
$21.3M 0.03%
204,115
+70,573
+53% +$7.46M
UBS icon
519
UBS Group
UBS
$176B
$21.3M 0.03%
1,876,410
+160,187
+9% +$1.8M
FBT icon
520
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
$21.2M 0.03%
171,396
-197,324
-54% -$26.3M
IWS icon
521
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
$21.2M 0.03%
236,398
-5,268
-2% -$467K
CBSH icon
522
Commerce Bancshares
CBSH
$8.5B
$21.1M 0.03%
490,518
+44,764
+10% +$1.87M
PRI icon
523
Primerica
PRI
$9.89B
$21M 0.03%
165,236
+6,457
+4% +$779K
INFO
524
DELISTED
IHS Markit Ltd. Common Shares
INFO
$21M 0.03%
313,979
+18,920
+6% +$1.24M
CHD icon
525
Church & Dwight Co
CHD
$24.5B
$20.9M 0.03%
278,265
-4,634
-2% -$351K

Similar funds

Raymond James & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Raymond James & Associates held 3,809 positions worth $71.7B, up 3.4% from $69.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q3 2019 filing shows 183 new, 1,708 increased, 1,572 reduced and 206 closed positions. Its largest new stake was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M. The largest sale was Microchip Technology, an estimated $155M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2019 buy was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M.
  • Raymond James & Associates added most to Comcast in Q3 2019, an estimated $203M increase.
  • Raymond James & Associates's biggest Q3 2019 reduction was Microchip Technology, cutting an estimated $155M.
  • Raymond James & Associates fully exited Anadarko Petroleum in Q3 2019, selling an estimated $89.3M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $71.7B portfolio in Q3 2019.
  • Raymond James & Associates opened 183 new positions and closed 206 in Q3 2019.
  • Raymond James & Associates's portfolio value rose 3.4% quarter-over-quarter to $71.7B.

Based on Raymond James & Associates's 13F filing for Q3 2019, filed 7 Nov 2019.